来自西孟加拉邦喜马拉雅以南地区的本土植物的神经功能通过反向药理学
Lepcha Tshering Dhendup1, Datta Sutapa1, Joongku Lee2
1Molecular Genetics Laboratory, Department of Botany, University of North Bengal, Raja Rammohanpur, Siliguri-734013, India.
Bioinformation
|November 16, 2023
概括
这项研究探索了喜马拉雅植物用于神经退行性疾病治疗,识别了穿越血脑屏障并准关键通路的化合物. 对于治疗应用,还需要进一步的研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 系统生物学 系统生物学
背景情况:
- 像阿尔茨海默氏症和帕金森症这样的神经退行性疾病是全球日益严重的健康问题.
- 常见的病理过程包括蛋白质积累,氧化应激和神经炎症.
- 网络药理学为多目标药物开发和重新利用提供了一个有前途的方法.
研究的目的:
- 识别来自喜马拉雅植物的生物活性化合物,对神经退行性疾病有潜在的治疗应用.
- 使用计算方法研究这些化合物的类似药物的特性和潜在的分子标.
- 通过路径丰富分析来探索作用的潜在机制.
主要方法:
- 从25种传统的喜马拉雅植物中选出730种生物活性化合物.
- 评估类似药物的特性 (ADME标准) 和血脑屏障的透性.
- 反向对接,药映射和功能/通路丰富分析用于目标识别.
主要成果:
- 287种化合物显示出有利的胃肠道吸收和血脑屏障的透性.
- 确定了171种潜在的点蛋白质,这些蛋白质涉及MAPK和神经营蛋白信号传递等途径.
- 瓦勒里亚娜·贾塔曼西 (Valeriana jatamansi) 显示与β-粉样蛋白结合有关,这与阿尔茨海默病有关.
结论:
- 喜马拉雅植物含有潜在治疗神经退行性疾病的化合物.
- 网络药理学有效地确定了候选药物及其相关的生物途径.
- 需要进一步的体外和体内研究来验证这些发现的治疗用途.
相关概念视频
01:26Neurochemical Transmission: Sites of Drug Action
2.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.2K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.2K
01:22CNS Stimulants: Psychedelic Agents
156
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
156
01:28Drugs Acting on Autonomic Ganglia: Blockers
1.0K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.0K